Deutsches Referenzzentrum für Ethik in den Biowissenschaften (DRZE)

Titel: ICPM 2004: 13th International Conference on Pharmaceutical Medicine

Termin: 19.9.2004, 12:30 Uhr, bis 22.9.2004, 15:30 Uhr

Veranstaltungsort:
Hotel Noga Hilton
Expolac Exhibition Centre
Quai du Mont-Blanc
1201 Geneva
Switzerland

Weitere Informationen:
http://www.icpm2004.org/welcome.htm

Kurzbeschreibung: We cordially invite you to attend the 13th International Conference on Pharmaceutical Medicine in Geneva, Switzerland. We are proud to host this meeting in our country for the first time and hope to make it a memorable event scientifically, operationally and socially.

“Simply Better Medicines” was chosen as the conference title and to remind us of our, 'raison d'être', as specialised physicians, to contribute to the discovery and development of new and better drugs which meet a medical need. In recent years, we have focussed on globalisation, harmonisation, the optimising of processes and information. We are now in a paradigm shift into genome driven drug discovery and pharmacogenetically segmented frontloaded and (bio-) informative drug development because of the new wealth of genome and proteome based drug targets and high number of small chemical and biological molecules. There is rising pressure on “higher throughput drug development” which is integrated and comprehensive, faster and eventually (hopefully) less expensive. This is an almost insurmountable task, particularly in the light of the increasing drug development deficit encountered with more drugs being developed in the small biotech technology industry.

The programme of the 13th ICPM Conference in Switzerland addresses some of these issues and focuses on coping with: the paradigm shift, new technologies including bio-informatics, systems biology and knowledge management, as well as simulation and modelling as they pertain to integrated drug development and more personalised use and better medicines. Ethical aspects which emerge from the practical use of new therapeutic interventions, e.g. gene therapy, will also be discussed.

Striving for better medicines in integrated and informative drug development demands better training and education in pharmaceutical medicines and postgraduate training programmes need to be harmonised. Specialist titles in pharmaceutical medicine are being acknowledged in several countries and mutual national/European recognition evolves.

Collaborative efforts are made to provide a continuing (pharmaceutical) medical education system. A comprehensive curriculum for specialisation in pharmaceutical medicine emerges.

We look forward to working with you at the Geneva Conference in an atmosphere of fascination and fun.

Kontakt: Mr. René Haller
MCI Suisse SA
75, rue de Lyon
1211 Geneva 13
Switzerland

Tel.: +41 - (0)22 - 3 39 96 26
Fax.: +41 - (0)22 - 3 39 96 21

rene.haller@mci-group.com

Schlagworte: Pharmazeutik

Artikelaktionen